Piramal Clinical Research (formerly known as Wellquest Clinical Research) is a Contract Research Organization specialized in bioequivalence and analytical studies. Piramal Clinical Research is a division of Piramal Healthcare Limited. With a state-of-the-art facility spread over 30,000 sq ft at Hyderabad, India, Piramal Clinical Research has capabilities for conducting bioavailability and bioequivalence studies, bioanalytical method development and validation, sample processing and analysis, statistical analysis and reporting.

Piramal Clinical Research is managed by a group of dedicated professionals with vast experience in clinical research. At Piramal Clinical Research, all operations are driven by GCP and GLP systems as well as applicable national and international regulations. Piramal Clinical Research has over 150 SOPs for clinical, bioanalytical and QA operations and more than 125 validated methods.

Piramal Clinical Research has been involved in more than 100 pivotal bioequivalence and pharmacokinetic studies. Piramal Clinical Research also has expertise in analytical work for new chemical entities (Phase I-III studies). Most of these studies have been carried out for international regulatory submissions - these include US FDA, UK MHRA, European Union, MCC-South Africa, and Thailand FDA. Piramal Clinical Research is authorized by the Drugs Controller General (India) and has been inspected by the US FDA and Department of Medical Sciences, Ministry of Public Health (Thailand). Our clients have received product approval for generics in US and EU for which the biostudies were done at Piramal Clinical Research.



Piramal Clinical Research has a state-of-the-art facility spread over 30, 000 sq ft at Hyderabad, India...

Read More